Belvedere Trading »

Cidara Therapeutics shares owned by Belvedere Trading

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2025-09-30 $358k 3.7k 95.76

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf (IWM)
Strategy Cl A New (MSTR)
Apple (AAPL)
Broadcom (AVGO)
Spdr Gold Tr Gold Shs Call Option (GLD)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Amazon (AMZN)
Advanced Micro Devices (AMD)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Palantir Technologies Cl A (PLTR)

View all positions for Belvedere Trading

Top funds holding Cidara Therapeutics

RA Capital Management
Bain Capital Life Sciences Investors
Point72 Asset Management
BVF
Vivo Capital
Vanguard Group
BlackRock
Darwin Global Management
Paradigm Biocapital Advisors
VR Adviser
Morgan Stanley
FMR
State Street Corporation
Citadel Advisors
Henderson Group

View all funds holding Cidara Therapeutics